Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

Cure Alzheimer’s Fund Awards Grant to University of Virginia for Innovative Research

Boston - A University of Virginia professor has been awarded a $100,000 grant by Cure Alzheimer’s Fund to continue his groundbreaking research on Alzheimer’s disease, the most common cause of dementia in the elderly, which currently affects 5.2 million Americans and their families.

George S. Bloom, Ph.D., will use the grant to continue his studies on a strain of antibodies thought to be able to recognize the proteins associated with Alzheimer’s.

Larry King highlights Alzheimer’s epidemic on CNN special Sunday, May 1

CNN will be airing the Larry King special “Unthinkable: the Alzheimer’s Epidemic” on Sunday, May 1 at 8:00 PM in most time zones. King will explore Alzheimer’s disease, the people it affects, its impact on their families, the latest in treatment, and why it is critical to find a cure for this devastating disease.

Progress for Alzheimer's in Washington

In September, Cure Alzheimer’s Fund representatives were invited by the White House to be panelists at a briefing on Alzheimer’s disease. At the White House Briefing on the Challenge of Alzheimer’s Disease in the United States, Tim Armour and Rudy Tanzi made presentations regarding the current state of Alzheimer’s research to senior members of the White House, Department of Health and Human Services, National Institutes of Health and representatives of many Alzheimer’s advocacy groups.

Bound for Everest

Fresh off of summiting Aconcagua, the highest peak in South America, Alan Arnette is at it again. This spring, he will attempt to summit Everest—the highest peak on Earth at 29,035 feet. Everest is the third mountain in his 7 Summits Climb for Alzheimer’s: Memories are Everything campaign—his yearlong mission to scale the highest peak on each of the seven continents to raise money for the fight against Alzheimer’s.

Relationship Between the APOE Genotype and Alzheimer's Disease

A meeting of the minds

One of the most important, outstanding genetic questions about Alzheimer’s disease is the relationship between the APOE genotype and the risk associated with the disease. To better understand this topic and speed progress, Cure Alzheimer’s Fund (CAF) sponsored a meeting in February 2010 to explore this issue. The body of biological knowledge regarding how and why APOE likely is linked with AD was discussed in detail by members of the CAF Research Consortium and Cheryl Wellington, Ph.D., University of British Columbia; Michael Brown, M.D., University of Texas; Karl Weisgraber, Ph.D., Gladstone Institute; Alan Tall, Ph.D., Columbia University; and Joachim Herz, M.D., University of Texas, whose record of research includes valuable insights into this relationship. The meeting led to some important, newly funded research, including a project by David Holtzman, M.D., in his lab at Washington University in St. Louis.

Dispatches from Alan Arnette at Everest base camp on his 7 Summits Climb for Alzheimer's

Alan Arnette, a long time Alzheimer’s Advocate and friend of The Cure Alzheimer’s Fund, is at base camp and is finalizing his training and preparing to summit Mt. Everest. This will be the third climb of his 7 Summits Climb for Alzheimer’s: Memories are Everything campaign where he is raising awareness and $1M for Alzheimer’s research. He took a few minutes to share his thoughts on Alzheimer’s research. Climb on Alan.


Dispatches from Everst Base Camp

Alzheimer’s Genes in the News: What does it all mean?

Setting the stage

The 10th Annual International Conference on Alzheimer’s Disease/Parkinson’s Disease (AD/PD) was held this March in Barcelona with thousands of researchers from 68 countries attending. Chief among the topics of interest was determining risk for the disease from genetics. The useful source for all things Alzheimer’s, The Alzheimer’s Research Forum (, provided extensive coverage on the conference.

Welcome Julie Ann Winton to the Cure Alzheimer’s Fund team!

Julie is joining Cure Alzheimer’s Fund as Development and Communications Associate to help provide content and direction to our communications program, support our fundraising efforts, help manage and expand our outreach programs and generally provide administrative support for Cure Alzheimer’s Fund and related researchers.

Deepak Chopra interviews CAF's Dr. Rudy Tanzi on this innovative Alzheimer's research

In this video Deepak Chopra talks to Dr. Rudy Tanzi about his groundbreaking research project, the Alzheimer's Genome Project, how gaining a better understanding of Alzheimer's disease leads to better treatments and a possible cure, and the important support of Cure Alzheimer's Fund in his research efforts.